SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-14-009914
Filing Date
2014-02-14
Accepted
2014-02-14 16:38:59
Documents
1
Period of Report
2013-07-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v368792_4a.html 4/A  
1 OWNERSHIP DOCUMENT v368792_4a.xml 4/A 3539
  Complete submission text file 0001144204-14-009914.txt   5113
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 210 MAIN STREET WEST C/O BIOSANTE PHARMACEUTICALS, INC. BAUDETTE MN 56623
Business Address
Jamnick Robert J. (Reporting) CIK: 0001579707 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 14617637